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ABSTRACT
Background    Performing multiple blood culture sets 
simultaneously is a standard blood culture methodology, 
although it is often difficult to distinguish true bactere-
mia from contamination when only one of several blood 
culture sets is positive. This study clarified the relation-
ship between the number of positive blood culture sets 
and clinical significance in patients with positive blood 
culture. 
Methods    Patients aged 18 years and over with at least 
1 positive blood culture were enrolled. Positive blood 
culture episodes were categorized from clinical records 
as true bacteremia, contamination, or unknown clinical 
significance. The associations among episodes of true 
bacteremia, isolated bacteria, the number of positive 
blood culture sets from among the performed sets, and 
the clinical background of patients were analyzed.
Results    Among a total of 407 episodes, 262, 67 and 
78 were true bacteremia, contamination and unknown 
clinical significance, respectively. The positive predic-
tive values (PPVs) of 1 out of 1, 1 out of 2 and 2 out of 
2 positive sets in cases of Staphylococcus aureus, were 
81.3%, 50% and 100% respectively; those in cases of 
coagulase-negative Staphylococci were 20.5%, 10.8% 
and 63.5%, respectively. Almost all cases of Escherichia 
coli, Pseudomonas aeruginosa, Klebsiella species and 
Candida species were true bacteremia. The probability 
of true bacteremia was strongly associated with recent 
surgery in multivariate analysis (P < 0.05).
Conclusion    The probability of true bacteremia based 
on the number of positive culture sets from among the 
performed sets varies by microorganism. Therefore, 
PPVs calculated using this method may help physicians 
distinguish true bacteremia from contamination. 
 
Key words    bacteremia; blood culture; contamination; 
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Bacteremia is often fatal and requires early diagnosis 
and treatment with adequate antimicrobial agents.1, 2 
Blood culture is regarded as the gold standard for the 
diagnosis of bacteremia.3 However, accurately judging 
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the clinical significance of culture results is challenging 
because of possible culture contamination. Therefore, 
methods to help differentiate true bacteremia from con-
tamination are required.
 The identification of isolated bacteria from positive 
blood cultures is a helpful clue for estimating the prob-
ability of true bacteremia. This probability, which is 
often expressed as the positive predictive value (PPV), is 
reported to vary by microorganism. For example, when 
Streptococcus pneumoniae, Escherichia coli, other 
members of Enterobacteriaceae, Pseudomonas aeru-
ginosa and Candida albicans are isolated from blood 
culture, more than 90% are reported to be true bactere-
mia or fungemia.4–7 On the other hand, when coagulase-
negative Staphylococci (CNS), Corynebacterium species 
and Bacillus species are isolated, the probability of true 
bacteremia is reported to be low.4–10 However, most of 
these studies were performed in the 70s through the 90s. 
Therefore, updated data in current patient populations 
and treatment methods are needed, because the ratio and 
causative bacteria of bloodstream infections might have 
changed over time as a result of the increasing use of 
intravascular devices and number of patients receiving 
immunomodulatory treatment.11, 12
 Another method for distinguishing true bacteremia 
from contamination is using the number of blood cul-
ture sets (each set of blood culture consists of an aerobic 
and anaerobic bottle containing different nutrients) that 
grow bacteria from among the performed culture sets. 
Opportunities to adopt this methodology are increasing, 
because the recently approved Clinical and Labora-
tory Standards Institute (CLSI) guideline recommends 
more than 2 sets of blood culture should be performed 
simultaneously (within minutes of one another) in pa-
tients suspected blood stream infection.13 However, it is 
often difficult to interpret the results when only 1 of the 
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2 blood culture sets is positive. In such cases, the results 
should be interpreted cautiously according to the identity 
of the isolated bacteria. In accordance with this strategy, 
the PPV of positive blood culture according to the num-
ber of positive blood culture sets has been examined for 
CNS.7, 14 However, data about other microorganisms are 
rare.
 Therefore, this study aimed to provide information 
to facilitate the interpretation of positive blood cultures 
by analyzing the clinical significance of isolated mi-
croorganisms, the number of positive blood culture sets 
from among the performed sets, and clinical background 
characteristics of patients in current clinical settings..
 
SUBJECTS AND METHODS
Patients and blood culture
Patients aged 18 years and over with at least one posi-
tive blood culture from April 1, 2007 to March 31, 2010 
at Tottori University Hospital—a 700-bed tertiary-care 
facility—were evaluated. Blood was collected by the 
doctors, residents, or nurses and inoculated into standard 
aerobic and anaerobic bottles (BacT/ALERT FA and FN; 
Biomerieux, Durham, NC). One pair of these culture 
bottles was defined as 1 blood culture set. The bottles 
were incubated in the BacT/ALERT 3D System (Organon 
Teknika, Durham, NC) until flagged as positive or for 
7 days at 37 °C. At least 2 sets of blood cultures were 
recommended to be obtained simultaneously or in rapid 
succession from separate vein puncture sites. However, 2 
sets performed on the same day (at intervals of up to 24 
h) were considered contiguous. Susceptibility testing of 
isolated bacteria was performed according to the CLSI 
guidelines. The significance of positive blood culture 
was judged retrospectively on the basis of clinical re-
cords. This study was conducted according to the Ethi-
cal Guidelines for Clinical Studies of the Ministry of 
Health, Labour and Welfare, Japan, and patient consent 
was not required as this was a retrospective case note 
review that involved anonymized data.
 
Definitions
An episode of bacteremia or fungemia was defined as 
the first positive blood culture result or a new positive 
blood culture result that occurred more than 48 h after 
the previous positive result unless it was clear to the in-
vestigator that the new positive culture blood was part of 
the same episode.
 The clinical significance of a positive blood culture 
was determined by 1 infectious disease specialist and 2 
residents on the basis of clinical records. Clinical signifi-
cance was categorized as true bacteremia, contamina-
tion or unknown significance. Assessments were made 
on the basis of the following factors as described by 
Weinstein et al.:7 clinical history, physical findings, vital 
signs (i.e., body temperature, blood pressure and heart 
rate) at the time of blood culture, white blood cell count, 
repeated isolation of the same bacteria at intervals more 
than 24 h, time until positive blood culture result, results 
of cultures from other sites, imaging results, histopatho-
logic findings, clinical course, response to antimicrobial 
therapy, presence of a plausible source and clinical man-
ifestations. The number of positive blood culture bottles 
within a blood culture set was not used as a criterion to 
differentiate true bacteremia from contamination in the 
present study, because previous studies have reported on 
its inefficacy.8, 15
 
Clinical background characteristics
The principal investigator reviewed the medical records 
and recorded the following clinical characteristics that 
were possibly related to true bacteremia on a standard-
ized form: demographic variables, renal function, 
immunosuppressed conditions, presence of vascular 
catheter, location in the intensive care unit at blood cul-
ture collected, preceding antibiotic use, recent surgery, 
recent trauma and nosocomial acquisition. Preceding 
antibiotics use was defined as the use of any antibiotics 
at the time of blood culture collection. Recent surgery or 
trauma was defined as surgery or trauma within 30 days 
before blood culture collection. Each episode was clas-
sified as community or nosocomial acquired according 
to the guidelines of the Centers for Disease Control and 
Prevention.16 An episode in a patient from another hospi-
tal or nursing home was always classified as nosocomial 
acquired.
 
Statistical analysis 
PPV—which is the probability that an isolated organ-
ism would be expected to be a true pathogen rather than 
a contaminant—was calculated as the number of true 
bacteremic episodes divided by the number of positive 
blood culture episodes with the organism. Univariate 
analysis was performed to explore the association be-
tween the collected clinical characteristics and presence 
of true bacteremia. Categorical variables were assessed 
by the chi2 test or Fisher’s exact test. Continuous vari-
ables were analyzed using Student’s t-test. Variables 
significant in univariate analysis were entered into the 
multivariate analysis, which was performed by logistic 
regression. All analyses were performed with SPSS ver-
sion 19.0 (SPSS Inc., Chicago, IL), the level of signifi-
cance was set at P < 0.05.
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RESULTS
Among a total of 407 episodes, 262, 67 and 78 were true 
bacteremia or fungemia, contamination and unknown 
clinical significance, respectively. First, we examined 
the frequency of each microorganism and the relation-
ships between their identity and clinical significance. As 
shown in Table 1, the most common microorganisms 
isolated from blood culture were CNS; only 21.7% (20/92) 
of these episodes were true bacteremia. Nevertheless, 
CNS was the third most frequent causative pathogen 
of true bacteremia because of its high prevalence. The 
second most frequently isolated microorganism from 
blood culture was Staphylococcus aureus; 83.8% (67/80) 
of episodes were true bacteremia, making it the most 
common cause of true bacteremia. All 6 Streptococcus 
pneumoniae isolates were pathogens for true bacteremia. 
The frequency of isolation and true bacteremia of other 
gram-positive bacteria were relatively low. Escherichia 
coli was the third most common microorganism isolated 
from blood culture and the most frequently isolated 
gram-negative bacteria. Almost all episodes involving 
gram-negative bacteria including Escherichia coli were 
true bacteremia and none were contamination. Anaero-
bic bacteria such as Bacteroides fragilis or fungi isolated 
from blood culture represented true bacteremia; no epi-
sodes were contamination. Fungi isolated from blood 
culture were all Candida species; Candida albicans was 
frequently isolated more than other Candida species.
 As mentioned above, the CLSI guidelines recom-
mend multiple blood culture sets be performed simulta-
neously, but it is often difficult to determine if an isolate 
is the true pathogen of bacteremia or a contaminant 
when only 1 culture set is positive. Knowing the proba-
bility of true bacteremia in such situations, i.e., the PPV, 
is critical. Therefore, we subsequently examined the 
relationship between the number of positive culture sets 
and the probabilities of their clinical significance regard-
ing major isolated microorganisms (Table 2). In the case 
of Staphylococcus aureus, the PPVs of a positive culture 
in 1 positive set out of 1 and 2 positive sets out of 2 were 
Table 1. Microorganisms isolated from the blood of patients suspected of bacteremia at Tottori University Hospi-
tal from April 2007 through March 2010
 Microorganism (episode) True bacteremia (%) Contamination (%) Unknown (%)
 Aerobic and facultative bacteria
 Gram positive
  Staphylococcus aureus (80) 67 (83.8)   2 (2.5) 11 (13.8)
  Cagulase-negative staphylococci (92) 20 (21.7) 50 (54.3) 22 (23.9)
  Bacillus species (30) 14 (46.7) 10 (33.3)   6 (20)
  Enterococcus species (26) 15 (57.7)   1 (3.8) 10 (38.5)
  Corynebacterium species (4)   0   2 (50)   2 (50)
  Streptococcus pneumonia (6)   6 (100)   0   0
  Viridans streptococci (4)   3 (75)   0   1 (25)
  Other streptococci (6)   3 (50)   0    3 (50)
  Other gram positive bacteria (5)   0   2 (40)   3 (60)
 Gram negative
  Escherichia coli (39) 35 (89.7)   0   4 (10.3)
  Klebsiella pneumonia (19) 16 (84.2)   0   3 (15.8)
  Klebsiella oxytoca (5)   4 (80)   0   1 (20)
  Psudomonas aeruginosa (19) 17 (89.5)   0   2 (10.5)
  Enterobacter cloacae (8)   7 (87.5)   0   1 (12.5)
  Serratia marcessens (7)   5 (71.4)   0   2 (28.6)
  Proteus mirabilis (2)   2 (100)   0   0
  Stenotrophomonas maltophilia (2)   2 (100)   0   0
  Acinetobacter species (5)   4 (80)   0   1 (20)
  Citrobacter species (4)   4 (100)   0   0
  Other gram negative bacteria (7)    5 (71.4)   0   2 (28.6)
Anaerobic bacteria
 Bacteroides fragilis (10) 10 (100)   0   0
 Fusobacterium necrophorum (2)   2 (100)   0   0
 Other gram positive bacteria (8)   7 (87.5)   0   1 (12.5)
 Other gram negative bacteria (2)   1 (50)   0   1 (50)
Fungi
 Candida albicans (5)   5 (100)   0   0
 Other Candida species (10)   8 (80)   0   2 (20)
All Microorganisms (407) 262 (64.3) 67 (16.5) 78 (19.2)
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Table 3. Relationship between clinical background and significance in patients with positive blood cultures
   True bacteremia (n = 262) Contamination (n = 67) P
  Sex      0.40†
 Male  167 (63.7%) 39 (58.2%)
 Female 95 (36.3%) 28 (41.8%)
Age, years
 Mean ± SD 68.1 ± 14.7 70.0 ± 14.3 0.36§
 Range 17–94 22–89
eGFR, mL/min/1.73m2     0.85†
 < 10.0 11 (5.3%) 2 (4.2%)
 10.0–49.9 54 (26.1%) 11 (22.9%)
 50.0 ≤ 143 (68.6%) 35 (72.9%)
 No date 54  19
Immunosuppressed
 DM 79 (30.2%) 12 (17.9%) 0.046†
 Malignant tumor 132 (50.4%) 31 (46.3%) 0.55†
 Corticosteroid use 36 (13.7%) 10 (14.9%) 0.80†
 Immunosuppressor (except corticosteroid) use 4 (1.5%) 4 (6.0%) 0.057‡
Any vascular catheter present (except arterial catheter) 183 (69.8%) 42 (62.7%) 0.26†
 Peripheral IV catheter present 126 (48.1%) 22 (32.8%) 0.025†
 CV catheter present 80 (30.5%) 22 (32.8%) 0.72†
 CV port system present 19 (7.3%) 2 (3.0%) 0.16‡
Location in ICU  48 (18.3%) 12 (17.9%) 0.94†
Preceding antibiotics use  97 (37.0%) 33 (49.3%) 0.068†
Recent surgery 54 (20.6%) 4 (6.0%) 0.010†
Recent trauma  9 (3.4%) 2 (3.0%) 0.61‡
Nosocominal acquisition 204 (77.9%) 50 (74.6%) 0.57†
  CV, Central venous; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; ICU, Intensive care unit; IV, intravenous.
† Chi2 test.
‡ Fisher’s exact test.
§ t-test.
Table 2. Clinical significance of each microorganism according to the number of positive blood culture sets
  Number of culture sets
Microorganism (episode) Positive Performed True bacteremia Contamination Unknown
 Staphylococcus aureus (80) 1 1 39 (67.2%) 2 (3.4%) 7 (12.1%)
 1 2 4 (50%) 0 (0%) 4 (50%)
 2 2 24 (100%) 0 (0%) 0 (0%)
Cagulase-negative staphylococci (92) 1 1 9 (20.5%) 24 (54.5%) 11 (25%)
 1 2 4 (10.8%) 24 (64.9%) 9 (24.3%)
 2 2 7 (63.6%) 2 (18.2%) 2 (18.2%)
Bacillus species (30) 1 1 4 (40%) 4 (40%) 2 (20%)
 1 2 3 (27.3%) 6 (54.5%) 2 (18.2%)
 2 2 7 (77.8%) 0 (0%) 2 (22.2%)
Enterococcus species (26) 1 1 9 (60%) 1 (6.7%) 5 (33.3%)
 1 2 2 (50%) 0 (0%) 2 (50%)
 2 2 4 (57.1%) 0 (0%) 3 (42.9%)
Escherichia coli (39) 1 1 14 (87.5%) 0 (0%) 2 (12.5%)
 1 2 9 (81.8%) 0 (0%) 2 (18.2%)
 2 2 12 (100%) 0 (0%) 0 (0%)
Klebsiella species (24) 1 1 8 (72.7%) 0 (0%) 3 (27.3%)
 1 2 2 (66.7%) 0 (0%) 1 (33.3%)
 2 2 10 (100%) 0 (0%) 0 (0%)
Psudomonas aeruginosa (19) 1 1 9 (90%) 0 (0%) 1 (10%)
 1 2 4 (100%) 0 (0%) 0 (0%)
 2 2 3 (75%) 0 (0%) 1 (25%)
Candida species (15) 1 1  8 (88.9%) 0 (0%) 1 (11.1%)
 1 2 0 (0%) 0 (0%) 0 (0%)
 2 2 5 (83.3%) 0 (0%) 1 (16.7%)
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81.3% and 100%, respectively. Meanwhile, the PPV in 1 
positive set out of 2 was only 50%. In the case of CNS, 
a representative bacteria of the normal flora of the skin, 
the PPVs of 1 positive set out of 1 and 2 positive sets out 
of 2 were 20.5% and 63.6% respectively. However, when 
1 out of 2 sets was positive, the PPV was only 10.8% 
and almost all cases were contamination. In the case of 
Bacillus species, which are also part of the normal flora 
of the skin, the PPVs of 1 positive set out of 1, 2 positive 
sets out of 2 and 1 positive set out of 2 were 40%, 77.8% 
and 27.3%, respectively. In the case of Enterococcus 
species, the respective PPVs were 60%, 50% and 57.1%. 
Regarding gram-negative bacteria such as Escherichia 
coli, Klebsiella species and Pseudomonas aeruginosa as 
well as fungi, no cases were considered contamination 
irrespective of the number of positive culture sets, and 
almost all cases represented true bacteremia.
 The inclusion of clinical information facilitates the 
interpretation of positive blood culture results. Therefore, 
we subsequently evaluated the associations between 
clinical background characteristics and the existence 
of true bacteremia (Table 3). There were no significant 
differences in sex, age or estimated glomerular filtration 
rate between cases of true bacteremia and contamina-
tion. Regarding immunosuppressive conditions, the 
prevalence of diabetes was significantly higher in true 
bacteremia than contamination (30.2% versus 17.9%, 
respectively, P < 0.05). The presence of malignancy 
and corticosteroid and immunosuppressor use were not 
significantly different between groups. An intravenous 
catheter was introduced in 69.8% and 62.7% of cases of 
true bacteremia and contamination, respectively, and the 
indwelling peripheral intravenous catheters were more 
frequently observed in cases of true bacteremia than in 
cases of contamination (48.1% versus 32.8%, respec-
tively, P < 0.05). However, such significant differences 
were not observed with central venous catheters and 
central venous port systems. With regard to other clini-
cal factors, the patients with true bacteremia were more 
likely to have recent surgery, compared with those with 
contamination (20.6% versus 6.0%, respectively, P < 
0.05). There was no significant difference between the 2 
groups with respect to location in the intensive care unit, 
previous antibiotic use, recent trauma or nosocomial 
acquisition. Finally, the significant clinical factors in the 
univariate analysis were entered into the multivariate 
model (Table 4). However, the presence of recent surgery 
was the only independent risk factor for true bacteremia 
(odds ratio: 3.74, P < 0.05).
DISCUSSION
This study investigated the clinical significance of iso-
lated microorganisms, the number of positive blood 
culture sets from among the performed culture sets, and 
presence of predisposing factors in order to facilitate the 
interpretation of positive blood culture results. In par-
ticular, this study is the first to report the probabilities of 
true bacteremia and contamination based on the number 
of positive culture sets with microorganisms besides 
CNS. Our data suggest that taking into account the num-
ber of positive blood culture sets in combination with 
the identity of isolated bacteria and clinical background 
characteristics is helpful for distinguishing between true 
bacteremia and contamination.
 In this study, we revealed that causative pathogens 
of true bacteremia in order of frequency were Staphylo-
coccus aureus (25.6%), Escherichia coli (13.4%), CNS 
(7.6%), Pseudomonas aeruginosa (6.5%) and Klebsi-
ella pneumoniae (6.1%). These frequencies have been 
changed over time. In the middle of 1970’s, the causative 
pathogen of true bacteria were reported that Escherichia 
coli (16.3%), Staphylococcus aureus (10%), Streptococ-
cus pneumoniae (6.3%), Klebsiella pneumoniae (6.3%) 
and Pseudomonas aeruginosa (5.3%).6 The same au-
thors analyzed the data in 1990’s and reported the fre-
quencies as Staphylococcus aureus (18.9%), Escherichia 
coli (15%), CNS (9.2%), Klebsiella pneumoniae (6.9%) 
and Enterococcus species (6.9%).7 In the beginning of 
2000’s, Pien et al. reported the frequencies as Staphy-
lococcus aureus (23.1%), Escherichia coli (12.5%), En-
terococcus species (9.4%), Klebsiella pneumoniae (8.2%) 
and CNS (7.7%).4 Comparing these historical data with 
ours, the emerging increase of Staphylococcus aureus 
and CNS as causative pathogen of true bacteremia is ob-
vious. The increasing use of intravascular catheters and 
devises, in the modern medical settings may contribute 
to this drastic change. Therefore, we need to carefully 
interpret the clinical significance of these bacteria, when 
they isolated from blood cultures.
 Previous studies have reported that the probabil-
ity of true bacteremia or contamination depends on 
the identity of the isolated bacteria, and the data of the 
present study are consistent with those of other stud-
ies. Moreover, previous studies analyzed the data from 
the middle of 1970’s to 1990’s indicate that 90–100% 
Table 4. Logistic regression analysis of factors associ-
ated with true bacteremia and contamination
 Factors Odds raio P
 DM 1.91 0.065
Peripheral IV catheter present 1.65 0.090
Recent surgery 3.74 0.015
 DM, diabetes mellitus; IV, intravenous.
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of cases isolated of Escherichia coli, Klebsiella pneu-
moniae, Pseudomonas aeruginosa or Candida species 
are true bacteremia.4, 6, 7 In the present study, no episode 
was judged to be due to contamination. Therefore the 
probabilities of true bacteremia of these bacteria have 
not changed over time. On the other hand, the previous 
studies indicate that 6–12.4% of cases of CNS were bac-
teremia,4, 6, 7 in the present study, the probabilities were 
obviously increased to 21.7%. Thus, the results indicate 
that the probability of true bacteremia based on the iden-
tity of the isolated bacteria can be changeable with the 
times and should be estimated on the bases of updated 
data in current patient populations. 
  Although it is recommended that at least 2 sets 
of blood cultures taken from separate vein puncture 
sites be obtained,13, 18 there is little available informa-
tion to aid the interpretation of the clinical significance 
of positive blood cultures, especially in cases in which 
only 1 of several blood culture sets is positive. To our 
knowledge, CNS is the only microorganism whose PPV 
has been determined on the basis of the number of posi-
tive blood culture sets from among the performed sets. 
Weinstein et al. report that the PPVs of 1 and 2 positive 
sets out of 2 are 2.2% and 60.0%, respectively;7 in their 
study, 2 blood culture sets were performed within 48 
h but the interval between each blood culture was not 
documented. Meanwhile, Beekmann et al. report that 
the PPVs of 1 and 2 positive sets out of 2 were 13% and 
69%, respectively;14 their data were drawn from blood 
culture sets that were performed within 5 days of the in-
dex positive blood culture. In the present study, the PPVs 
of 1 and 2 positive sets out of 2 were 10.8% and 63.3%, 
respectively, in cases involving CNS in 2 blood culture 
sets performed simultaneously. As the recent guideline 
recommends blood cultures be obtained simultaneously 
or in rapid succession (< 24 h),13 the present findings 
provides consistent evidence of the PPV for CNS bacte-
remia.
 The present study revealed that when gram-negative 
bacteria such as Escherichia coli, Klebsiella species 
and Pseudomonas aeruginosa or Candida species are 
isolated, there is no difference in the PPV regardless 
of the number of positive culture sets from among the 
performed sets. Therefore, these bacteria should be con-
sidered true pathogens if isolated from at least 1 blood 
culture set. In the case of Staphylococcus aureus, the 
present results highlight the importance of considering 
the number of positive culture sets when interpreting the 
clinical significance of the findings, because the PPV 
of blood culture varied greatly depending on number of 
positive culture sets. Therefore, when Staphylococcus 
aureus is isolated from blood culture, especially if 1 out 
of 2 sets is positive, the clinical significance must be 
judged very cautiously. Regarding other gram-positive 
bacteria such as Bacillus species and Enterococcus 
species, the PPV of 1 positive set out of 2 was compara-
tively low; even 2 positive sets out of 2 does not always 
indicate true bacteremia for these bacteria. The present 
study shows that the PPV of blood culture based on the 
number of positive culture sets varies with respect to the 
isolated microorganism. Therefore, the approach utiliz-
ing the number of positive culture sets from among the 
performed sets must be combined with the identity of 
the isolated bacteria; thus, the probability of true bacte-
remia should be interpreted cautiously according to the 
isolated bacteria.
 The present study shows that recent surgery is an 
independent risk factor for true bacteremia. This result 
is similar to that of Marschall et al., who report that a 
history of urogenital surgery is associated with urinary-
source bacteremia in patients with Escherichia coli bac-
teriuria.19 In addition to the invasion of bacteria from the 
wound site, we speculate that immunosuppression due 
to the stress of surgery is related to bacteremia. Previ-
ous experimental and clinical studies provide evidence 
indicating surgery decreases both cell-mediated and 
humoral immunity, affecting the host immune system. 
Major surgical invasion is reported to depress the func-
tions of monocytes and20, 21 macrophages22, 23 as well as 
decrease T-lymphocyte proliferation and cytokine secre-
tion.24 Furthermore, the decreased interleukin-2 produc-
tion by T lymphocytes as a result of surgical invasion 
is suggested to decrease B-cell antibody production.25 
Eventually, considering clinical background character-
istics such as the presence of recent surgery may help 
distinguish between true bacteremia and contamination, 
especially in cases in which the probability of true bac-
teremia is ambiguous after considering the number of 
positive blood culture sets from among the performed 
sets.   
 In conclusion, when utilizing the number of positive 
blood culture sets to distinguish true bacteremia from 
contamination, the variation in the probability of true 
bacteremia by the microorganism must be considered. 
This study demonstrates that PPV calculated on the ba-
sis of the number of positive culture sets from among the 
preformed sets according to the identity of the isolated 
bacteria is helpful for interpreting the clinical signifi-
cance of positive blood cultures. 
The authors declare no conflict of interest.
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